Werbung
Werbung

MYNZ

MYNZ logo

Mainz Biomed N.V. Ordinary Shares

1.18
USD
Gesponsert
0.00
+0.43%
09. Jan., 15:58 UTC -5
Geschlossen
exchange

Nach-Markt

1.17

-0.01
-1.27%

MYNZ Ergebnisberichte

Positives Überraschungsverhältnis

MYNZ übertreffen die 2 der letzten 4Schätzungen.

50%

Nächster Bericht

Datum des nächsten Berichts
30. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$2.04
Implizierte Änderung von Q2 25 (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
--

Mainz Biomed N.V. Ordinary Shares earnings per share and revenue

On 26. Sept. 2025, MYNZ reported earnings of -- USD per share (EPS) for Q2 25, -- the estimate of -2.44 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 3 analysts forecast an EPS of -2.04 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q2 2025, Mainz Biomed N.V. Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for 30. März 2026.
Based on 3 analysts, Mainz Biomed N.V. Ordinary Shares is expected to report EPS of -$2.04 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung